Cardiac sympathetic nerve function assessed by [131I]metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs

Journal of Nuclear Cardiology

Volumn 4, Issue 1, 1997, Pages 33-41

  Takatsu, Hisato ^a   Duncker, Carlos M ^a   Arai, Masazumi ^a   Becker, Lewis C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Coronary artery occlusion; Desipramine; Myocardial infarction; Myocardium; Phenol; Sympathectomy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; DESIPRAMINE; PHENOL; RADIOPHARMACEUTICAL AGENT; (3 IODOBENZYL)GUANIDINE; ADRENERGIC RECEPTOR AFFECTING AGENT; ADRENERGIC RECEPTOR BLOCKING AGENT; COLORING AGENT; DIAGNOSTIC AGENT; IODOBENZENE; PHENOL DERIVATIVE; RADIOACTIVE IODINE; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DOG; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; COMPARATIVE STUDY; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NERVE ENDING; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; COLORING AGENTS; DESIPRAMINE; DOGS; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; NERVE ENDINGS; PHENOL; PHENOLS; RADIOPHARMACEUTICALS; SYMPATHECTOMY, CHEMICAL; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; TETRAZOLIUM SALTS;

EID: 0030889262     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90047-7     Document Type: Article

References (41)

1. 131I]iodobenzylguanidine. J Nucl Med 1980;21:349-53.
2. Minardo JD, Tuli MM, Mock BH, et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988;78:1008-19.
3. Dae MW, O'Connell JW, Botvinick EH, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79:634-44.
4. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-26.
5. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416-23.
6. Dae MW, Botvinick EH. Imaging cardiac neurons and receptors. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, editors. Cardiac imaging: a companion to Braunwald's heart disease. Philadelphia: WB Saunders, 1991:1135-9.
7. Nishimura T, Oka H, Sago M, et al. Serial assessment of denervated but viable myocardium following acute myocardial infarction in dogs using iodine-123 metaiodobenzylguanidine and thallium-201 chloride myocardial single photon emission tomography. Eur J Nucl Med 1992;19:25-9.
8. Spinnler MT, Lombardi F, Moretti C, et al. Evidence of functional alterations in sympathetic activity after myocardial infarction. Eur Heart J 1993;14:1334-43.
9. Glowniak JV, Turner FE, Gray LL, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182-91.
10. Nohara R, Kambara H, Okuda K, et al. Effects of cardiac sympathetic nervous system on the stunned myocardium experimental study with 123I-metaiodobenzylguanidine. Jpn Circ J 1991;55:893-9.
11. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-4.
12. Zipes DP. Influence of myocardial ischemia and infarction on autonomie innervation of heart. Circulation 1990;82:1095-105.
13. Rossi L. Neuroanatomopathology of the cardiovascular system. In: Kulbertus HE, Franck G, editors. Neurocardiology. New York: Futura Publishing Company, 1988:25.
14. Schömig A, Dart AM, Dietz R, Mayer E, Kubler W. Release of endogeneous catecholamines in the ischemic myocardium of the rat, A: locally mediated release. Circ Res 1984;55:689-701.
15. Schömig A. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation 1990;82(Suppl II):II-13-22.
16. Tobes MC, Jacques S Jr, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985;26:897-907.
17. Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986;27:84-9.
18. Randall WC, Szentivanyi M, Wechsler JS, Kaye MP. Patterns of sympathetic nerve projections onto the canine heart. Circ Res 1968;22:315-23.
19. Geis WP, Kaye MP. Distribution of sympathetic fibers in the left ventricular epicardial plexus of the dog. Circ Res 1968;23: 165-70.
20. Heymann MA, Payne BD, Hoffman JI, Rudolph M. Blood flow measurements with radionuclide labelled particles. Prog Cardiovasc Dis 1977;20:50-79.
21. Fishbein M, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
22. Leftkowitz RJ, Hoffman BB, Taylor P. Neurohumoral transmission: the autonomic and somatic motor nervous systems. In: Gilman AG, Rail TW, Nies AS, Taylor P editors. The pharmaco logical basis of therapeutics. 8th ed. New York: Pergamon Press, 1990:84-121.
23. Martins JB, Zipes DP. Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 1980;47: 33-40.
24. Chilian WM, Boatwright RB, Shoji T, Griggs DM Jr. Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res 1981;49:866-76.
25. Sisson JC, Lynch JJ, Johnson J, et al. Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 1988;116:67-76.
26. 123I labeled methyl-branched fatty acid and sympathetic imaging in acute coronary syndrome. Nucl Med Commun 1995;16:494-503.
27. Heusch G, Guth BD, Roth DM, Seitelberger R, Ross J Jr. Contractile responses to sympathetic activation after coronary instrumentation. Am J Physiol 1987;253:H1059-69.
28. Dolezel A, Gerova M, Hartmannova B, Dostal M, Janeckova H, Vascu J. Cardiac adrenergic innervation after instrumentation of the coronary artery in dog. Am J Physiol 1984;246:H459-65.
29. Dae MW, Iwanaga S, Espy C, O'Connell JW, Botvinick EH, Huberty JP. Viability of sympathetic nerves versus myocytes in ischemic and reperfused myocardium [abstract]. J Nucl Cardiol 1995;2:S51.
30. Strashun A. Adriamycin, congestive cardiomyopathy, and metaiodobenzylguanidine. J Nucl Med 1992;33:215-22.
31. Lee H, Inbasekaran MN, Wieland DM, et al. Development of a kit-form analog of metaiodobenzylguanidine. J Nucl Med 1986; 27:256-67.
32. 131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 1983; 24:1127-34.
33. Paessens R, Borchard F. Morphology of cardiac nerves in experimental infarction of rat hearts, I: fluorescence microscopical findings. Virchows Arch A Pathol Anat Histol 1980;386:265-78.
34. Ahonen A, Härkönen J, Juntunen J, Kormano M, Penttild A. Effects of myocardial infarction on adrenergic nerves of the rat heart muscle, a histochemical study. Acta Physiol Scand 1975;93: 336-44.
35. Schmid PG, Greif BJ, Lund DD, Roskoski R Jr. Tyrosine hydroxylase and choline acetyltransferase activities in ischemic canine heart. Am J Physiol 1982;243:H788-95.
36. 131I]-MIBG in rats. Nucl Med Commun 1988;9:663-7.
37. Trendelenburg U. The extraneuronal uptake and metabolism of catecholamines in the heart. In: Paton DM, editor. The mechanism of neuronal and extraneuronal transport of catecholamines. New York: Raven Press, 1976:259.
38. Trendelenburg U. A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines. In: Adrian RH, et al., editors. Review of physiology, biochemistry and pharmacology. Vol. 87. New York: Springer-Verlag, 1980:34-89.
39. Abramson FB, Furst CL, McMartin C, Wade R. The isolation, identification and synthesis of two metabolites of guanethidine formed in pig and rabbit liver homogenates. Biochem J 1969;113: 143-56.
40. Dae MW, DeMarco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med 1992;33:1444-50.
41. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GN, Stewart JA, et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993;34:589-600.